A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)

Clinical trial NCT00230321 · COMPLETED

Trial details

NCT number: NCT00230321
Sponsor: Peter L Greenberg
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Blood Cancer Myelodysplastic Syndromes Myelodysplastic Syndromes (MDS)

Start date: 2002-02-01
Primary completion: 2007-11-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.